Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
49.20    0.00 (0.00%)
Bid:
48.40
Ask:
50.00
Spread: 1.60 (3.306%)
Market Cap: £188.87m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

1st Quarter - Interim Management Statement

30 Apr 2013 12:24

RNS Number : 6138D
British Smaller Companies VCT2 Plc
30 April 2013
 



 

British Smaller Companies VCT2 plc ("the Company")

 

Interim Management Statement

For the quarter ended 31 March 2013

 

British Smaller Companies VCT2 plc presents its interim management statement for the period from 1 January 2013 to 31 March 2013, including relevant financial information from the end of that period to 30 April 2013, being the date of this announcement. This constitutes the Company's first interim management statement for the financial year ending 31 December 2013, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmep.com.

 

The total return at 31 March 2013, calculated by reference to the net asset value per ordinary share and the cumulative dividends paid per ordinary share, was 101.3 pence per ordinary share. In the quarter there has been an increase of 1.3 pence per ordinary share in the total return to shareholders (equivalent to 1.3%) mainly as a result of the increase in valuation seen in the Company's unquoted investment portfolio.

 

The unaudited net asset value per ordinary share as at 31 March 2013 was 66.8 pence representing an increase of 1.3 pence per ordinary share (equivalent to 2%) from 65.5 pence per ordinary share as at 31 December 2012. These figures are before any provision for the proposed final dividend of 2.5 pence per ordinary share in respect of the year to 31 December 2012. This level of dividend is an increase of 0.5 pence per ordinary share on the 2011 final dividend. If the final dividend is approved at the Company's Annual General Meeting on 20 May 2013 it will be paid on 5 June 2013 to shareholders on the register as at 3 May 2013.

 

The number of ordinary shares in issue at 31 March 2013 was 41,457,844 (31 December 2012: 41,457,844). In addition, at 31 March 2013, the Company held 1,252,761 ordinary shares in treasury (31 December 2012: 1,252,761).

 

 

Net assets at 31 March 2013 comprised the following:

£000

% of net assets

Unquoted investments at fair value

9,930

35.9

Quoted investments at bid price

1,669

6.0

Gilt investments

915

3.3

Total investments

12,514

45.2

Cash and cash equivalents

7,702

27.8

Cash on fixed term deposit

7,048

25.5

Other net current assets

414

1.5

Net assets

27,678

54.8

 

The above cash balance includes £2.1 million relating to the allotment of shares on 31 December 2012.

 

The ten largest investments by valuation at 31 March 2013 were as follows:

 

£000

% of net assets

Displayplan Holdings Limited

1,638

5.9

Seven Technologies Holdings Limited

1,167

4.2

Digital Healthcare Limited

1,059

3.8

Immunobiology Limited

987

3.6

Deep-Secure Limited

983

3.6

Insider Technologies (Holdings) Limited

806

2.9

Bluebell Telecoms Group Limited

608

2.2

PowerOasis Limited

567

2.0

Waterfall Services Limited

434

1.6

Harvey Jones Holdings Limited

419

1.5

8,668

31.3

Other investments

2,931

10.6

Gilt investments

915

3.3

Total investments

12,514

45.2

 

 

During the three months ended 31 March 2013 the Company made one follow-on investment of £0.07 million into existing portfolio company PowerOasis Limited, a provider of energy management solutions to telecoms infrastructure operators. This investment was part of a significant $5 million investment round led by a strategic trade investor.

 

In the 3 months to 31 March 2013 aggregate cash proceeds of £0.41 million were received relating to the sale of the Company's holdings in Tikit Group plc and May Gurney Integrated Services plc generating a profit on cost of £0.07 million in the quarter.

 

Following the end of the quarter, on 5 April 2013 the Company issued 4,428,298 new ordinary shares as part of the linked offer with British Smaller Companies VCT plc, raising £2,907,109 million net of costs. Unquoted portfolio business Cambridge Cognition Limited has also achieved a successful listing on the AiM market raising £5m to fund sales growth of its cognitive testing software.

 

On 18 April 2013 the Company purchased 279,961 ordinary shares at a price of 59.20 pence per ordinary share. These shares are held in treasury.

 

Performance

 

The portfolio value increased by 1.4 pence per ordinary share in the quarter although growth in net asset value per ordinary share was slightly lower at 1.3 pence including other costs. The majority of this increase is attributed to the unquoted investments with several investee companies reporting profit growth in the period.

 

Outlook

 

The Board believes that the current economic climate will continue to create investment opportunities in the short to medium term in well run and managed UK businesses that need capital to expand but are facing a shortage of finance. History has shown us that cautious investments made in the low point of the economic cycle have resulted in the highest portfolio returns. Additionally the investment limit applying to venture capital trusts has been increased to £5 million per investment in any one year. A number of investment opportunities are currently being assessed for investment and the Company is well placed to take advantage of these following the recent new share issue.

 

 

30 April 2013

 

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 294 5039

Matt Thomas N+1 Singer Tel: 0207 496 3000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSURAAROSASOAR
Date   Source Headline
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares
6th Dec 20229:58 amRNSOffer Update
6th Dec 20229:58 amRNSOffer Update
30th Nov 202212:30 pmRNSPublication of a Prospectus
30th Nov 202212:30 pmRNSPublication of a Prospectus
25th Nov 20229:30 amRNS3rd Quarter Results
4th Nov 20228:30 amRNSDividend Declaration
24th Oct 20229:00 amRNSChange of Registrar
3rd Oct 20221:30 pmRNSOffer Update
3rd Oct 20221:30 pmRNSOffer Update
3rd Oct 202212:24 pmRNSPayment of Dividend and Issue of Equity
28th Sep 202211:12 amRNSTransaction in Own Shares
20th Sep 20229:30 amRNSHalf-year Report
4th Aug 202211:45 amRNSDividend Declaration
2nd Aug 20221:15 pmRNSStatement re intention to fundraise
2nd Aug 20221:15 pmRNSStatement re intention to fundraise
29th Jun 202210:00 amRNSPurchase of Own Securities and Net Asset Value
21st Jun 20223:00 pmRNSInterim Management Statement
13th Jun 20223:51 pmRNSResult of AGM
6th May 20229:14 amRNSPayment of dividend and Issue of Equity
30th Mar 20228:00 amRNSTransaction in Own Shares
21st Mar 20221:15 pmRNSAnnual Financial Report
25th Feb 202212:03 pmRNSResult of General Meeting
31st Jan 202212:00 pmRNSPublication of Circular
7th Jan 202211:15 amRNSDirector/PDMR Shareholding
7th Jan 202211:15 amRNSDirector/PDMR Shareholding
7th Jan 202211:15 amRNSDirector/PDMR Shareholding
7th Jan 202211:15 amRNSIssue of Equity and Close of Offers
16th Dec 20219:57 amRNSTransaction in Own Shares
6th Dec 202110:37 amRNSPublication of Supplementary Prospectus
6th Dec 202110:33 amRNSPublication of Supplementary Prospectus
18th Nov 20218:08 amRNSInterim Management Statement
16th Nov 202110:06 amRNSPayment of dividend and allotment of shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.